Successful treatment of breakthrough bacteremia due to Pseudomonas aeruginosa with recombinant human granulocyte colony-stimulating factor in a patient with acute leukemia.
Funada
H
H
Protected Environment Unit, Kanazawa University School of Medicine, Japan.
Mizuhashi
K
K
Machi
T
T
Ohtake
S
S
Matsuda
T
T
D000900:Anti-Bacterial Agents; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000209:etiology / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000209:etiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor